02 July 2019

Meeting report: 3rd Pulmonary Vascular Diseases Summit, Tabriz, Iran, 27-28 June 2019

The 3rd Pulmonary Vascular Diseases Summit was held on 27-28 June, in Tabriz, Iran.


The Summit was well attended with 400 delegates, including pulmonologists, cardiologists, radiologists, internists and GPs from Iran.

The opening ceremony saw professor Simonneau, Emeritus Professor at the Paris-Sud University, France, and esteemed PVRI Board member, honoured for his prominent and valuable service to PH patients and for promoting the discipline worldwide.


The CTEPH session - Evaluation of CTEPH patients for endarterectomy and management of complications - provided by video conference by Dr  Michael Madani  (USA) attracted a strong 400 audience. The second video conference showed Dr Stefano Barco (Germany) presenting two topics: 'Prevention of early complications and late consequences after acute pulmonary embolism' and 'Use of old and new anticoagulants in special population (short bowel syndrome, anti-phospholipid syndrome, elderly, pregnancy)', which were also very popular.

The faculty included 12 international speakers from seven countries. Countries represented were:

  • Belgium
  • France
  • Germany
  • Japan
  • Turkey
  • Czech Republic
  • United States.

All delegates indicated the PDV learning outcomes will benefit their patients. 

We would like to thank the three PVRI sponsored speakers for their input and contribution:

  • Professor Marion Delcroix
  • Professor Irene Lang
  • Professor Gerald Simonneau.

The delegates also had a chance to visit some of Tabriz historical places, such as the Bazaar and rug manufactory with its beautiful and traditional Persian carpets.

The Summit Scientific Committee would like to extend their thanks and gratitude to the esteemed faculty for making this event a memorable one and hopes to organise another meeting in 2021.


The PVRI would like to thank Dr Farid Rashidi (pictured above) and his colleagues for organising such a exciting event.

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI